Authors: Bensen, WG Zhao, SZ Burke, TA Zabinski, RA Makuch, RW Maurath, CJ Agrawal, NM Geis, GS

Citation: Wg. Bensen et al., Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo, J RHEUMATOL, 27(8), 2000, pp. 1876-1883

Authors: Agrawal, NM Campbell, DR Safdi, MA Lukasik, NL Huang, B Haber, MM

Citation: Nm. Agrawal et al., Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers - Results of a double-blind, randomized, multicenter study, ARCH IN MED, 160(10), 2000, pp. 1455-1461

Authors: Goldstein, JL Silverstein, FE Agrawal, NM Hubbard, RC Kaiser, J Maurath, CJ Verburg, KM Geis, GS

Citation: Jl. Goldstein et al., Reduced risk of upper gastrointestinal ulcer complications with celecoxib a novel COX-2 inhibitor, AM J GASTRO, 95(7), 2000, pp. 1681-1690

Authors: Agrawal, NM Caldwell, J Kivitz, AJ Weaver, AL Bocanegra, TS Ball, J Dhadda, S Hurley, S Hancock, L

Citation: Nm. Agrawal et al., Comparison of the upper gastrointestinal safety of Arthrotec (R) 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers, CLIN THER, 21(4), 1999, pp. 659-674